Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Keisuke Matsumura
Contemporary Trend of Reduced-Dose Non-Vitamin K Anticoagulants in Japanese Patients With Atrial Fibrillation: A Cross-Sectional Analysis of a Multicenter Outpatient Registry
Journal of Cardiology
Cardiovascular Medicine
Cardiology
Related publications
Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation
Therapeutic Advances in Cardiovascular Disease
Cardiovascular Medicine
Pharmacology
Cardiology
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Novel Anticoagulants Versus Vitamin K Antagonists for Cardioversion of Non- Valvular Atrial Fibrillation – A Meta-Analysis of More Than 17000 Patients
Scientific Reports
Multidisciplinary
Role of Non-Vitamin K Oral Anticoagulants for Prevention of Stroke in Renal Impaired Atrial Fibrillation Patients
ACI (Acta Cardiologia Indonesiana)
Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants
Journal of Medical Economics
Health Policy
Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion
Journal of Clinical Trials in Cardiology
Safety of Once- Or Twice-Daily Dosing of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients With Nonvalvular Atrial Fibrillation: A NOAC-TR Study
Bosnian Journal of Basic Medical Sciences
Medicine
Non-Vitamin K Oral Anticoagulants Versus Warfarin for Patients With Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights
Cardiovascular Therapeutics
Medicine
Cardiovascular Medicine
Pharmacology
Cardiology
